Brief: Kwangdong Pharmaceutical Q2 Consolidated Operating Profit 5 Billion Won, Down 57.7% From Year Earlier
12/08/2024 09:47
Kwangdong Pharmaceutical Co Ltd 009290.KS :
* KWANGDONG PHARMACEUTICAL: Q2 CONSOLIDATED OPERATING PROFIT
5
BILLION WON, DOWN 57.7% FROM YEAR EARLIER
Source text for Eikon: ID:
Further company coverage: 009290.KS
Recent news on Kwangdong Pharmaceutical
See all newsBrief: Kwangdong Pharmaceutical Q2 Operating Profit 2.8 Billion Won, Down 38% From Year Earlier
Brief: Kwangdong Pharmaceutical To Divest 25 Billion Won Worth Of Own Shares
Brief: Kwangdong Pharmaceutical To Divest 22 Billion Won Worth Of Own Shares
Ocugen up after licensing deal for ophthalmic gene therapy in South Korea
Brief: Kwangdong Pharmaceutical Q1 Operating Profit 3.3 Billion Won, Down 80.6% From Year Earlier